Health topic

Bone

Reveal the impact of antiresorptive
treatment in just 3 months.
 

Gaining efficacy results in just 3 months will increase the likelihood your patient remains compliant with therapy—which will increase her chances of avoiding a dreaded fracture.

With a menu of highly specific bone marker assays—such as the Elecsys β-CrossLaps—that determine how well her osteoporosis medications are working, there’s no longer a need to wait 2 years for your patient’s next DXA scan.

alt
Find out how Roche can help you assure her and safeguard her compliance. Call (800) 346-8606 (select option 2).
Learn more

References

1. National Osteoporosis Foundation. What Women Need to Know. National Osteoporosis Foundation site. https://www.nof.org/preventing-fractures/general-facts/what-women-need-to-know. Accessed November 20, 2018. 

2. What is osteoporosis? National Osteoporosis Foundation Web site. https://nof.org/articles/7. Accessed November 20, 2018. 

3. Warriner AH, Curtis JR. Adherence to osteoporosis treatments: room for improvement. Curr Opin Rheumatol. 2009;21(4):356-362. 

4. Bonnick SL, Shulman L. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? Am J Med. 2006;119(4A):25S-31S.

*Due to osteoporosis; in women over age 50.

Products
Category
Found 0 results in
Filters
...
    ...